In a letter to Drug Enforcement Administration (DEA) Administrator Anne Milgram, 14 Republican lawmakers urged the company to reject the Division of Well being and Human Providers (HHS) advice to reclassify hashish from Schedule I below the Managed Substances Act to Schedule III.
“It’s irresponsible for HHS to suggest that marijuana be faraway from Schedule I. It will even be irresponsible for DEA to behave on this advice,” the letter states. “Our nation depends on DEA to implement our nation’s drug legal guidelines. We ask you to uphold your mission by rejecting any effort to take away marijuana from Schedule I.”
The letter cites Nationwide Institute on Drug Abuse (NIDA) analysis that means that 30% of hashish customers have marijuana use dysfunction, claims that hashish has larger THC content material than 25 years in the past, an American Academy of Pediatrics examine that means a 1,375% enhance in unintentional hashish edible ingestion by youngsters below 6 between 2017 and 2021, and former DEA denials of petitions to reclassify hashish.
The letter contends that hashish “doesn’t have a at present accepted medical use,” and notes that the Meals and Drug Administration (FDA) accredited medicine that comprise both man-made or natural hashish are non-intoxicating.
“The FDA has by no means accredited marijuana as a therapy for any illness or situation,” the letter states.
The letter is signed by Senators James Lankford and Markwayne Mullin (OK), Michael Rounds (SD), Mike Crapo and James Risch (ID), Marsha Blackburn (TN), Ted Budd (NC), and Tom Cotton (AR), together with Representatives Pete Classes (TX), Chuck Edwards (NC), Robert Aderholt (AL), Hal Rogers (KY), Earl “Buddy” Carter (GA), and Andy Biggs (AZ).
Get each day hashish enterprise information updates. Subscribe